OSE Pharma SA Capital Reinvestment Ratio
OSE Pharma SA capital reinvestment ratio. OSE Pharma SA (OSE) has a Capital Reinvestment Ratio of 0.00x as of June 2024, meaning it reinvests 0% of its operating cash flow (€66.63 Million) in capital expenditures (€18.00K). Check OSE capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of OSE Pharma SA (2016–2024)
Capital reinvestment ratio of OSE Pharma SA from 2016 to 2024. This chart tracks OSE Pharma SA's Capital Reinvestment Ratio across 4 annual periods. Also explore OSE year-over-year net asset growth to track the company's year-over-year net asset growth rate.
OSE Pharma SA Capital Reinvestment Ratio by Year (2016–2024)
OSE Pharma SA capital reinvestment ratio by year from 2016 to 2024. For the full cash flow conversion analysis, see OSE cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | €48.44 Million | €77.00K | ▼ -95.8% |
| 2019 | 0.04x | €8.97 Million | €336.00K | ▼ -93.2% |
| 2018 | 0.55x | €1.08 Million | €593.00K | ▲ +1155.4% |
| 2016 | 0.04x | €684.00K | €30.00K | — |